BR0315840A - Fosfolipìdeos de anel substituìdo anti-protozoários - Google Patents

Fosfolipìdeos de anel substituìdo anti-protozoários

Info

Publication number
BR0315840A
BR0315840A BR0315840-3A BR0315840A BR0315840A BR 0315840 A BR0315840 A BR 0315840A BR 0315840 A BR0315840 A BR 0315840A BR 0315840 A BR0315840 A BR 0315840A
Authority
BR
Brazil
Prior art keywords
protozoan
phospholipids
substituted ring
compounds
ring
Prior art date
Application number
BR0315840-3A
Other languages
English (en)
Inventor
Alexandros Makriyannis
Theodora Calogeropoulou
Maria Koufaki
Nikaolaos Avlonitis
Original Assignee
Makscientific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Makscientific Corp filed Critical Makscientific Corp
Publication of BR0315840A publication Critical patent/BR0315840A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FOSFOLIPìDEOS DE ANEL SUBSTITUìDO ANTI-PROTOZOáRIOS". São revelados novos fosfolipídeos contendo anel representados pela fórmula estrutural A-X-PO~ 3~ -W e sais fisiologicamente aceitáveis desses e um processo para a preparação desses compostos. Os compostos podem ser usados para o tratamento de doenças por protozoários e especialmente leishmaniose.
BR0315840-3A 2002-10-30 2003-10-29 Fosfolipìdeos de anel substituìdo anti-protozoários BR0315840A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42238302P 2002-10-30 2002-10-30
PCT/US2003/034225 WO2004041167A2 (en) 2002-10-30 2003-10-29 Antiprotozoal ring-substituted phospholipids

Publications (1)

Publication Number Publication Date
BR0315840A true BR0315840A (pt) 2005-09-27

Family

ID=32312498

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315840-3A BR0315840A (pt) 2002-10-30 2003-10-29 Fosfolipìdeos de anel substituìdo anti-protozoários

Country Status (7)

Country Link
US (1) US8097752B2 (pt)
EP (1) EP1578754A4 (pt)
CN (1) CN1742017A (pt)
AU (1) AU2003285071A1 (pt)
BR (1) BR0315840A (pt)
CA (1) CA2503058A1 (pt)
WO (1) WO2004041167A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101378005B1 (ko) * 2005-12-19 2014-03-27 아에테르나 젠타리스 게엠베하 세포독성이 감소된 알킬 인지질 유도체 및 이의 용도
AU2011284606A1 (en) * 2010-07-30 2013-03-14 Pharmacellion Ltd Compounds and methods for treating neoplasia
CN103665043B (zh) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
EP3334499A4 (en) 2015-08-14 2019-04-17 University of Massachusetts BIOACTIVE CONJUGATES FOR THE RELEASE OF OLIGONUCLEOTIDES
US10478503B2 (en) 2016-01-31 2019-11-19 University Of Massachusetts Branched oligonucleotides
US10844377B2 (en) 2017-06-23 2020-11-24 University Of Massachusetts Two-tailed self-delivering siRNA
JP2022528840A (ja) 2019-03-26 2022-06-16 ユニバーシティ・オブ・マサチューセッツ 安定性が増加した修飾オリゴヌクレオチド
MX2022001710A (es) 2019-08-09 2022-05-10 Univ Massachusetts Oligonucleótidos modificados químicamente dirigidos a los snp.
GR1010154B (el) 2020-09-22 2022-01-19 Quadrel S.R.L., Ενωση για χρηση στη θεραπεια πρωτοζωικων ασθενειων και διαδικασια παραγωγης της εν λογω ενωσης

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2209553A1 (en) * 1972-12-08 1974-07-05 Anvar Phosphorylated-cholines - as lipotropic, anti-steatosis antitoxic, choleretic and liver cell protecting agents
US5087721A (en) * 1987-10-23 1992-02-11 The University Of Michigan Radioiodinated phosphate esters
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US6254879B1 (en) * 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
US5463028A (en) * 1992-04-03 1995-10-31 The Trustees Of Columbia University In The City Of New York Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents
WO1998055533A1 (en) * 1997-06-04 1998-12-10 Biocompatibles Limited Zwitterionic compounds and their use to cross-link collagenous materials
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
US6344576B1 (en) 1997-08-18 2002-02-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Phospholipid-analogous compounds

Also Published As

Publication number Publication date
EP1578754A4 (en) 2006-07-19
AU2003285071A1 (en) 2004-06-07
CN1742017A (zh) 2006-03-01
WO2004041167A3 (en) 2004-09-16
AU2003285071A8 (en) 2004-06-07
EP1578754A2 (en) 2005-09-28
WO2004041167A2 (en) 2004-05-21
US20060105998A1 (en) 2006-05-18
CA2503058A1 (en) 2004-05-21
US8097752B2 (en) 2012-01-17

Similar Documents

Publication Publication Date Title
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BRPI0515218A (pt) composto, composição farmacêutica, método para o tratamento de um mamìfero ou ser humano, método de uso do composto, novos intermediários, uso dos novos intermediários, processo para a preparação de um composto
BR0213040A (pt) Composto, processo para preparar um composto, e, método de tratar doenças
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
HUP0303128A2 (hu) O-dezmetil-venlafaxin új szukcinátsója, eljárás az előállításukra, alkalmazása és ezt tartalmazó gyógyszerkészítmény
BR9401482A (pt) 1H-Indol-3-acetamida, formulação farmacêutica, utilização de um composto e processo para a preparação de 1h-indol-3-acetamida
MA27734A1 (fr) DERIVES HEXAHYDROPYRAZINO [1,2-a]PYRIMIDINE-4,7-DIONE SUBSTITUES SUR L'AZOTE, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
BRPI0409969A (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
BRPI0409627A (pt) 2-hidróxi-3-diaminoalcanos de fenacila
EA200401114A2 (ru) Замещённые гидроксиэтиламины
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
BR9812837A (pt) Processo para fazer um composto, e, composto
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
BR0212787A (pt) Composto ou sal farmaceuticamente aceitável do mesmo, métodos de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto ou sal, e, composição farmacêutica
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
UY27842A1 (es) Fluorobenzamidas
BR0315840A (pt) Fosfolipìdeos de anel substituìdo anti-protozoários
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
SE0101322D0 (sv) Novel compounds
BR0213481A (pt) Sondas
BR0308786A (pt) Derivados de ftalimido como inibidores da monoamina oxidase b
AR041678A1 (es) Formas cristalinas de clorhidrato de donepezil
BR9507381A (pt) Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos
BR9808923A (pt) Composto, e, processo para fazer o mesmo

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A. E 7A.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.